Style | Citing Format |
---|---|
MLA | Asghariazar V, et al.. "Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study." Prostaglandins and Other Lipid Mediators, vol. 174, no. , 2024, pp. -. |
APA | Asghariazar V, Karimi A, Adeli S, Kadkhodayi M, Zare E, Vajdi M, Nasimi Doost Azgoomi R, Asghari Vostakolaei M (2024). Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study. Prostaglandins and Other Lipid Mediators, 174(), -. |
Chicago | Asghariazar V, Karimi A, Adeli S, Kadkhodayi M, Zare E, Vajdi M, Nasimi Doost Azgoomi R, Asghari Vostakolaei M. "Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study." Prostaglandins and Other Lipid Mediators 174, no. (2024): -. |
Harvard | Asghariazar V et al. (2024) 'Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study', Prostaglandins and Other Lipid Mediators, 174(), pp. -. |
Vancouver | Asghariazar V, Karimi A, Adeli S, Kadkhodayi M, Zare E, Vajdi M, et al.. Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study. Prostaglandins and Other Lipid Mediators. 2024;174():-. |
BibTex | @article{ author = {Asghariazar V and Karimi A and Adeli S and Kadkhodayi M and Zare E and Vajdi M and Nasimi Doost Azgoomi R and Asghari Vostakolaei M}, title = {Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study}, journal = {Prostaglandins and Other Lipid Mediators}, volume = {174}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Asghariazar V AU - Karimi A AU - Adeli S AU - Kadkhodayi M AU - Zare E AU - Vajdi M AU - Nasimi Doost Azgoomi R AU - Asghari Vostakolaei M TI - Anticancer Activity of Naringenin on Human Liposarcoma: An Experimental and Bioinformatic Study JO - Prostaglandins and Other Lipid Mediators VL - 174 IS - SP - EP - PY - 2024 ER - |